申请人:DANA-FARBER CANCER INSTITUTE, INC.
公开号:US20210038599A1
公开(公告)日:2021-02-11
The present invention relates to compounds, compositions and methods for treating diseases or conditions mediated by proteins of the SWI/SNF chromatin-remodeling complex, including PB1.